Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	scavenger receptor binding	FPR2 FPR3	3.90e-05	5	40	2	GO:0005124
GeneOntologyMolecularFunction	N-formyl peptide receptor activity	FPR2 FPR3	3.90e-05	5	40	2	GO:0004982
GeneOntologyMolecularFunction	complement receptor activity	FPR2 FPR3	3.51e-04	14	40	2	GO:0004875
GeneOntologyMolecularFunction	RAGE receptor binding	FPR2 FPR3	4.04e-04	15	40	2	GO:0050786
GeneOntologyMolecularFunction	polypeptide N-acetylgalactosaminyltransferase activity	GALNT12 GALNT2	7.27e-04	20	40	2	GO:0004653
GeneOntologyMolecularFunction	acetylgalactosaminyltransferase activity	GALNT12 GALNT2	2.23e-03	35	40	2	GO:0008376
MousePheno	abnormal vomeronasal sensory neuron physiology	FPR2 FPR3	4.74e-05	5	31	2	MP:0011678
MousePheno	abnormal vomeronasal organ physiology	FPR2 FPR3	4.74e-05	5	31	2	MP:0013596
Domain	Formyl_pep_2/3_rcpt	FPR2 FPR3	4.70e-06	2	41	2	IPR027347
Domain	LRRNT	SLITRK5 LRRC3 LRRC3C LRIT1	6.22e-05	98	41	4	IPR000372
Domain	LRRNT	SLITRK5 LRRC3 LRRC3C LRIT1	6.22e-05	98	41	4	SM00013
Domain	NHL	LRP1B TRIM32	2.09e-04	10	41	2	PF01436
Domain	Formyl_rcpt-rel	FPR2 FPR3	2.09e-04	10	41	2	IPR000826
Domain	NHL_repeat	LRP1B TRIM32	2.09e-04	10	41	2	IPR001258
Domain	Leu-rich_rpt	SLITRK5 LRRC3 FBXL15 LRRC3C LRIT1	3.03e-04	271	41	5	IPR001611
Domain	LRR_8	SLITRK5 LRRC3 LRRC3C LRIT1	5.27e-04	171	41	4	PF13855
Domain	Leu-rich_rpt_typical-subtyp	SLITRK5 LRRC3 LRRC3C LRIT1	6.00e-04	177	41	4	IPR003591
Domain	LRR_TYP	SLITRK5 LRRC3 LRRC3C LRIT1	6.00e-04	177	41	4	SM00369
Domain	Gal_mutarotase_SF_dom	GANAB MAN2C1	6.26e-04	17	41	2	IPR011013
Domain	-	SLITRK5 LRRC3 FBXL15 LRRC3C LRIT1	6.56e-04	321	41	5	3.80.10.10
Domain	L_dom-like	SLITRK5 LRRC3 FBXL15 LRRC3C LRIT1	7.23e-04	328	41	5	IPR032675
Domain	-	GALNT12 GALNT2 B4GALT3	7.44e-04	81	41	3	3.90.550.10
Domain	Nucleotide-diphossugar_trans	GALNT12 GALNT2 B4GALT3	9.47e-04	88	41	3	IPR029044
Domain	LRR	SLITRK5 LRRC3 LRRC3C LRIT1	9.65e-04	201	41	4	PS51450
Domain	LRR_1	SLITRK5 LRRC3 LRRC3C LRIT1	1.33e-03	219	41	4	PF00560
Domain	Ricin_B_lectin	GALNT12 GALNT2	1.37e-03	25	41	2	PF00652
Domain	RICIN	GALNT12 GALNT2	1.71e-03	28	41	2	SM00458
Domain	RICIN_B_LECTIN	GALNT12 GALNT2	1.71e-03	28	41	2	PS50231
Domain	Ricin_B_lectin	GALNT12 GALNT2	1.97e-03	30	41	2	IPR000772
Domain	Glycos_transf_2	GALNT12 GALNT2	1.97e-03	30	41	2	PF00535
Domain	Glyco_trans_2-like	GALNT12 GALNT2	1.97e-03	30	41	2	IPR001173
Domain	-	LRP1B TRIM32	3.31e-03	39	41	2	2.120.10.30
Domain	LDLR_class-A_CS	SSPOP LRP1B	3.48e-03	40	41	2	IPR023415
Domain	Ldl_recept_a	SSPOP LRP1B	4.38e-03	45	41	2	PF00057
Domain	-	SSPOP LRP1B	4.58e-03	46	41	2	4.10.400.10
Domain	6-blade_b-propeller_TolB-like	LRP1B TRIM32	4.58e-03	46	41	2	IPR011042
Domain	LDLRA_1	SSPOP LRP1B	4.98e-03	48	41	2	PS01209
Domain	LDLRA_2	SSPOP LRP1B	5.18e-03	49	41	2	PS50068
Domain	LDrepeatLR_classA_rpt	SSPOP LRP1B	5.18e-03	49	41	2	IPR002172
Domain	LDLa	SSPOP LRP1B	5.18e-03	49	41	2	SM00192
Domain	LRRNT	SLITRK5 LRRC3	6.04e-03	53	41	2	PF01462
Domain	SCAN	ZSCAN22 ZNF446	6.72e-03	56	41	2	SM00431
Domain	SCAN_BOX	ZSCAN22 ZNF446	7.19e-03	58	41	2	PS50804
Domain	SCAN	ZSCAN22 ZNF446	7.19e-03	58	41	2	PF02023
Domain	SCAN_dom	ZSCAN22 ZNF446	7.19e-03	58	41	2	IPR003309
Domain	Retrov_capsid_C	ZSCAN22 ZNF446	7.43e-03	59	41	2	IPR008916
Pathway	REACTOME_FORMYL_PEPTIDE_RECEPTORS_BIND_FORMYL_PEPTIDES_AND_MANY_OTHER_LIGANDS	FPR2 FPR3	1.22e-04	8	30	2	MM15110
Pathway	REACTOME_FORMYL_PEPTIDE_RECEPTORS_BIND_FORMYL_PEPTIDES_AND_MANY_OTHER_LIGANDS	FPR2 FPR3	1.22e-04	8	30	2	M27370
Pubmed	Resolvin D1 protects the liver from ischemia/reperfusion injury by enhancing M2 macrophage polarization and efferocytosis.	FPR2 FPR3	1.36e-06	2	41	2	27317426
Pubmed	Strain-specific Loss of Formyl Peptide Receptor 3 in the Murine Vomeronasal and Immune Systems.	FPR2 FPR3	1.36e-06	2	41	2	26957543
Pubmed	Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors.	FPR2 FPR3	1.36e-06	2	41	2	9151906
Pubmed	A vasculo-protective circuit centered on lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 operative in murine microcirculation.	FPR2 FPR3	1.36e-06	2	41	2	23733341
Pubmed	N-formyl peptide receptor 3 (FPR3) departs from the homologous FPR2/ALX receptor with regard to the major processes governing chemoattractant receptor regulation, expression at the cell surface, and phosphorylation.	FPR2 FPR3	1.36e-06	2	41	2	21543323
Pubmed	Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4).	FPR2 FPR3	1.36e-06	2	41	2	12172542
Pubmed	Reversal of β-Amyloid-Induced Microglial Toxicity In Vitro by Activation of Fpr2/3.	FPR2 FPR3	1.36e-06	2	41	2	32617132
Pubmed	Lipoxin A4 inhibits the production of proinflammatory cytokines induced by β-amyloid in vitro and in vivo.	FPR2 FPR3	1.36e-06	2	41	2	21501589
Pubmed	Nonredundant protective properties of FPR2/ALX in polymicrobial murine sepsis.	FPR2 FPR3	1.36e-06	2	41	2	25512512
Pubmed	Differential expression of members of the N-formylpeptide receptor gene cluster in human phagocytes.	FPR2 FPR3	1.36e-06	2	41	2	8198572
Pubmed	N-Formylated humanin activates both formyl peptide receptor-like 1 and 2.	FPR2 FPR3	1.36e-06	2	41	2	15465011
Pubmed	Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses.	FPR2 FPR3	1.36e-06	2	41	2	17084101
Pubmed	A novel rat lipoxin A4 receptor that is conserved in structure and function.	FPR2 FPR3	1.36e-06	2	41	2	12746227
Pubmed	ALOX5AP Overexpression in Adipose Tissue Leads to LXA4 Production and Protection Against Diet-Induced Obesity and Insulin Resistance.	FPR2 FPR3	4.06e-06	3	41	2	27207555
Pubmed	Defective formyl peptide receptor 2/3 and annexin A1 expressions associated with M2a polarization of blood immune cells in patients with chronic obstructive pulmonary disease.	FPR2 FPR3	4.06e-06	3	41	2	29544524
Pubmed	Formyl peptide receptors are candidate chemosensory receptors in the vomeronasal organ.	FPR2 FPR3	4.06e-06	3	41	2	19497865
Pubmed	Formyl peptide receptor 2 regulates monocyte recruitment to promote intestinal mucosal wound repair.	FPR2 FPR3	4.06e-06	3	41	2	31585047
Pubmed	FoxO4 mediates macrophage M2 polarization by promoting LXA4R expression in an ovalbumin-induced allergic asthma model in mice.	FPR2 FPR3	4.06e-06	3	41	2	37422776
Pubmed	Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant.	FPR2 FPR3	4.06e-06	3	41	2	15879124
Pubmed	The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells.	FPR2 FPR3	4.06e-06	3	41	2	19234121
Pubmed	Functional expression of formyl peptide receptor family in human NK cells.	FPR2 FPR3	4.06e-06	3	41	2	19843937
Pubmed	Helicobacter pylori HP(2-20) induces eosinophil activation and accumulation in superficial gastric mucosa and stimulates VEGF-alpha and TGF-beta release by interacting with formyl-peptide receptors.	FPR2 FPR3	4.06e-06	3	41	2	24067461
Pubmed	Formyl peptide receptor 1 up-regulation and formyl peptide receptor 2/3 down-regulation of blood immune cells along with defective lipoxin A4/resolvin D1 production in obstructive sleep apnea patients.	FPR2 FPR3	4.06e-06	3	41	2	31116781
Pubmed	Formyl peptide receptors from immune and vomeronasal system exhibit distinct agonist properties.	FPR2 FPR3	4.06e-06	3	41	2	22859307
Pubmed	Identification, cloning, and functional characterization of a murine lipoxin A4 receptor homologue gene.	FPR2 FPR3	4.06e-06	3	41	2	12218158
Pubmed	Formyl peptide receptors and the regulation of ACTH secretion: targets for annexin A1, lipoxins, and bacterial peptides.	FPR2 FPR3	4.06e-06	3	41	2	17218541
Pubmed	Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production.	FPR2 FPR3	4.06e-06	3	41	2	20435922
Pubmed	Phagocyte activation by Trp-Lys-Tyr-Met-Val-Met, acting through FPRL1/LXA4R, is not affected by lipoxin A4.	FPR2 FPR3	4.06e-06	3	41	2	12410796
Pubmed	Formyl peptide receptor 2 is an emerging modulator of inflammation in the liver.	FPR2 FPR3	4.06e-06	3	41	2	36750693
Pubmed	Characterization of two new members of the formyl peptide receptor gene family from 129S6 mice.	FPR2 FPR3	4.06e-06	3	41	2	12459252
Pubmed	Formyl peptide receptor-like 2 is expressed and functional in plasmacytoid dendritic cells, tissue-specific macrophage subpopulations, and eosinophils.	FPR2 FPR3	4.06e-06	3	41	2	19342677
Pubmed	International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.	FPR2 FPR3	4.06e-06	3	41	2	19498085
Pubmed	Deletion of Annexin A1 in Mice Upregulates the Expression of Its Receptor, Fpr2/3, and Reactivity to the AnxA1 Mimetic Peptide in Platelets.	FPR2 FPR3	4.06e-06	3	41	2	36834844
Pubmed	Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms.	FPR2 FPR3	8.12e-06	4	41	2	12560218
Pubmed	Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19.	FPR2 FPR3	8.12e-06	4	41	2	1612600
Pubmed	The N-formylpeptide receptor (FPR) and a second G(i)-coupled receptor mediate fMet-Leu-Phe-stimulated activation of NADPH oxidase in murine neutrophils.	FPR2 FPR3	8.12e-06	4	41	2	12470609
Pubmed	An annexin 1 N-terminal peptide activates leukocytes by triggering different members of the formyl peptide receptor family.	FPR2 FPR3	8.12e-06	4	41	2	15187149
Pubmed	Lipoxin A4 attenuates hyperoxia‑induced lung epithelial cell injury via the upregulation of heme oxygenase‑1 and inhibition of proinflammatory cytokines.	FPR2 FPR3	8.12e-06	4	41	2	31746387
Pubmed	Biosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: effects of monensin on glycosylation and transport.	GANAB MAN2C1 B4GALT3	1.15e-05	37	41	3	2542563
Pubmed	Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1.	GANAB MAN2C1 B4GALT3	1.15e-05	37	41	3	2541446
Pubmed	Evidence that mannosyl residues are involved in human immunodeficiency virus type 1 (HIV-1) pathogenesis.	GANAB MAN2C1 B4GALT3	1.25e-05	38	41	3	2829950
Pubmed	Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1.	GANAB MAN2C1 B4GALT3	1.25e-05	38	41	3	2187500
Pubmed	Convergence of FPR-rs3-expressing neurons in the mouse accessory olfactory bulb.	FPR2 FPR3	1.35e-05	5	41	2	23664818
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	MTMR3 SMG5 CAND1 GALNT2 HSD17B4 CABIN1 LRP1B TRIM32 B4GALT3	1.50e-05	1285	41	9	35914814
Pubmed	Glycosylation and processing of the human immunodeficiency virus type 1 envelope protein.	GANAB MAN2C1 B4GALT3	2.23e-05	46	41	3	2649653
Pubmed	Bacterial MgrB peptide activates chemoreceptor Fpr3 in mouse accessory olfactory system and drives avoidance behaviour.	FPR2 FPR3	2.84e-05	7	41	2	31653840
Pubmed	Formyl peptide receptor-like proteins are a novel family of vomeronasal chemosensors.	FPR2 FPR3	2.84e-05	7	41	2	19387439
Pubmed	Differential expansion of the N-formylpeptide receptor gene cluster in human and mouse.	FPR2 FPR3	4.86e-05	9	41	2	9722950
Pubmed	Clustering of vomeronasal receptor genes is required for transcriptional stability but not for choice.	FPR2 FPR3	4.86e-05	9	41	2	36383665
Pubmed	Ubiquitin ligase TRIM71 suppresses ovarian tumorigenesis by degrading mutant p53.	TOPBP1 CUL7	7.41e-05	11	41	2	31570706
Pubmed	Local anesthetics impair the growth and self-renewal of glioblastoma stem cells by inhibiting ZDHHC15-mediated GP130 palmitoylation.	MTMR3 GANAB SSPOP	8.22e-05	71	41	3	33541421
Pubmed	Chemosensory Cell-Derived Acetylcholine Drives Tracheal Mucociliary Clearance in Response to Virulence-Associated Formyl Peptides.	FPR2 FPR3	8.88e-05	12	41	2	32294408
Pubmed	CSA and CSB proteins interact with p53 and regulate its Mdm2-dependent ubiquitination.	CAND1 CUL7	1.22e-04	14	41	2	22032989
Pubmed	Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells.	GANAB MAN2C1	1.82e-04	17	41	2	2355006
Pubmed	Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II.	CAND1 GANAB CUL7 LRP1B	1.95e-04	244	41	4	30349055
Pubmed	COMMD1 (copper metabolism MURR1 domain-containing protein 1) regulates Cullin RING ligases by preventing CAND1 (Cullin-associated Nedd8-dissociated protein 1) binding.	CAND1 CUL7	2.54e-04	20	41	2	21778237
Pubmed	Glycosylation inhibitors and neuraminidase enhance human immunodeficiency virus type 1 binding and neutralization by mannose-binding lectin.	GANAB MAN2C1	2.54e-04	20	41	2	12560567
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	WDR7 SSPOP PCLO	2.62e-04	105	41	3	9628581
Pubmed	Effect of various glycosidase treatments on the resistance of the HIV-1 envelope to degradation.	GANAB MAN2C1	3.09e-04	22	41	2	9109416
Pubmed	Folding of the human immunodeficiency virus type 1 envelope glycoprotein in the endoplasmic reticulum.	GANAB MAN2C1	3.09e-04	22	41	2	11530211
Pubmed	Overexpression of Galnt3 in chondrocytes resulted in dwarfism due to the increase of mucin-type O-glycans and reduction of glycosaminoglycans.	GALNT12 GALNT2	3.09e-04	22	41	2	25107907
Pubmed	Influence of N-linked glycans in V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response.	GANAB MAN2C1	3.09e-04	22	41	2	8673525
Pubmed	Role of asparagine-linked glycosylation in human immunodeficiency virus type 1 transmembrane envelope function.	GANAB MAN2C1	3.38e-04	23	41	2	1736542
Pubmed	Glycosylation inhibitors block the expression of LAV/HTLV-III (HIV) glycoproteins.	GANAB MAN2C1	3.38e-04	23	41	2	3099781
Pubmed	Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain.	GANAB MAN2C1	3.38e-04	23	41	2	8093218
Pubmed	Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1.	GANAB MAN2C1	3.38e-04	23	41	2	3264072
Pubmed	PlexinA1 signaling directs the segregation of proprioceptive sensory axons in the developing spinal cord.	SLITRK5 LRRC3 LRIT1	3.60e-04	117	41	3	17145500
Pubmed	Galnt11 regulates kidney function by glycosylating the endocytosis receptor megalin to modulate ligand binding.	GALNT12 GALNT2	3.68e-04	24	41	2	31740596
Pubmed	Loss of the disease-associated glycosyltransferase Galnt3 alters Muc10 glycosylation and the composition of the oral microbiome.	GALNT12 GALNT2	3.68e-04	24	41	2	31882545
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TOPBP1 CERK SPG11 SMG5 CAND1	3.81e-04	529	41	5	14621295
Pubmed	Effect of N-(3-phenyl-2-propenyl)-1-deoxynojirimycin on the lectin binding to HIV-1 glycoproteins.	GANAB MAN2C1	4.00e-04	25	41	2	2283726
Pubmed	The DNA sequence of human chromosome 22.	MTMR3 CCDC117 CERK CABIN1	4.27e-04	300	41	4	10591208
Pubmed	Site-specific N-glycosylation and oligosaccharide structures of recombinant HIV-1 gp120 derived from a baculovirus expression system.	GANAB MAN2C1	4.33e-04	26	41	2	8218172
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	TOPBP1 CUL7 SSPOP	4.90e-04	130	41	3	12421765
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	GALNT12 CAND1 GANAB GALNT2 TRIM32 DYNC2H1	7.78e-04	942	41	6	31073040
Pubmed	Galnt1 is required for normal heart valve development and cardiac function.	GALNT12 GALNT2	8.33e-04	36	41	2	25615642
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	SMYD4 TRIML1 MMS22L CABIN1	8.71e-04	363	41	4	14691545
Pubmed	O-glycosylation modulates integrin and FGF signalling by influencing the secretion of basement membrane components.	GALNT12 GALNT2	1.03e-03	40	41	2	22643896
Pubmed	Phosphorylation switches protein disulfide isomerase activity to maintain proteostasis and attenuate ER stress.	CAND1 GANAB GALNT2	1.14e-03	174	41	3	32149426
Cytoband	19q13.3-q13.4	FPR2 FPR3	6.03e-05	13	41	2	19q13.3-q13.4
Cytoband	10q24.32	AS3MT FBXL15	2.12e-04	24	41	2	10q24.32
Cytoband	19q13.43	ZSCAN22 ZNF446	2.77e-03	87	41	2	19q13.43
GeneFamily	Formyl peptide receptors	FPR2 FPR3	6.44e-06	3	27	2	198
GeneFamily	Polypeptide N-acetylgalactosaminyltransferases	GALNT12 GALNT2	4.01e-04	20	27	2	433
Drug	t-boc-MLP	FPR2 FPR3	1.89e-05	4	41	2	CID000125627
Drug	Danazol [17230-88-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A	FBXL15 SMG5 MAN2C1 CABIN1 DYNC2H1	2.43e-05	193	41	5	5315_UP
Drug	Homochlorcyclizine dihydrochloride [1982-36-1]; Down 200; 10.4uM; MCF7; HT_HG-U133A	MTMR3 SMG5 MAN2C1 WDR7 PSD4	2.49e-05	194	41	5	5998_DN
Drug	Scopolamin-N-oxide hydrobromide [6106-81-6]; Up 200; 10uM; PC3; HT_HG-U133A	MTMR3 SLITRK5 FBXL15 CABIN1 ZNF446	2.75e-05	198	41	5	2099_UP
Drug	Iodipamide [606-17-7]; Down 200; 3.6uM; MCF7; HT_HG-U133A	FBXL15 SMG5 WDR7 DYNC2H1 PCLO	2.88e-05	200	41	5	5510_DN
Drug	cyclooctylamine	FPR2 FPR3	3.15e-05	5	41	2	CID000002903
Drug	bacteriochlorin A	FPR2 FPR3	4.72e-05	6	41	2	CID000159279
Drug	L-phosphatidyl-glycerol	FPR2 FPR3	4.72e-05	6	41	2	CID000454706
Drug	dimethylfumarate	FPR2 FPR3	4.72e-05	6	41	2	CID000010262
Drug	L-valine methyl ester hydrochloride	FPR2 FPR3	8.80e-05	8	41	2	CID000094285
Drug	Fmlp Ome	FPR2 FPR3	8.80e-05	8	41	2	CID000122066
Drug	AC1L524D	FPR2 FPR3	8.80e-05	8	41	2	CID000196667
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	SPG11 GALNT2	2.97e-03	61	39	2	EFO_0008317, EFO_0008596, EFO_0020946
Disease	HDL cholesterol change measurement, physical activity	GALNT2 FPR3	3.06e-03	62	39	2	EFO_0003940, EFO_0007805
Disease	total lipids in small VLDL	GALNT2 HSD17B4	3.56e-03	67	39	2	EFO_0022148
Disease	phospholipids:total lipids ratio, intermediate density lipoprotein measurement	SPG11 GALNT2	3.56e-03	67	39	2	EFO_0008595, EFO_0020946
Disease	Alzheimer disease, educational attainment	AS3MT FBXL15 LRP1B	4.24e-03	247	39	3	EFO_0011015, MONDO_0004975
Disease	Disproportionate short stature	CUL7 DYNC2H1	4.68e-03	77	39	2	C0878659
Disease	C-reactive protein measurement	LRRC3C MMS22L SPG11 GALNT2 SSPOP PSD4	4.73e-03	1206	39	6	EFO_0004458
Disease	neuroticism measurement, cognitive function measurement	MMS22L GALNT2 LRP1B PCLO	6.48e-03	566	39	4	EFO_0007660, EFO_0008354

Protein segments in the cluster

Peptide	Gene	Start	Entry
EEWDCLFLHDVDLLP	B4GALT3	186	O60512
AELCAGPNDWILCAH	CCDC117	91	Q8IWD4
ICLHDIRKPECQGWE	FTHL17	81	Q9BXU8
PWHCDCALQEVLRQV	LRRC3C	161	A6NJW4
KLWLCEEHPLSLCEQ	ANKRD13B	371	Q86YJ7
IPIRWLCDGIHDCVD	LRP1B	3646	Q9NZR2
LHCCLTLCDFWEPNI	MMS22L	406	Q6ZRQ5
LDRCICVLHPVWAQN	FPR2	121	P25090
PLHCECALQEALWEL	LRRC3	146	Q9BY71
HCECNEHWLEPLLER	GALNT2	226	Q10471
LDRCICVLHPAWAQN	FPR3	121	P25089
SVRLCHQWALECEEL	IL17RE	201	Q8NFR9
NIWALLLKHCECAEE	CAND1	931	Q86VP6
PHLTEIQEWLCLNCQ	PCLO	1096	Q9Y6V0
LLPWHEAVDACMACL	CUL7	701	Q14999
NPWACDCRLYDLVHL	LRIT1	201	Q9P2V4
ELWDQPLLCNCLEIN	DYNC2H1	26	Q8NCM8
LRCNPDHWPCLDNLI	CABIN1	151	Q9Y6J0
CPEEQLCHLWLQTLR	CERK	106	Q8TCT0
EYVAPLVLWLCHESC	HSD17B4	216	P51659
ALHLEALCEEDLLLW	DENND6A	531	Q8IWF6
CECHEGWLEPLLQRI	GALNT12	231	Q8IXK2
CGLVIPEHLENCWIL	AS3MT	61	Q9HBK9
CWLHLSLPVQEAILC	MAN2C1	986	Q9NTJ4
ERCPVFLQWLDCVHQ	MTMR3	471	Q13615
PKGQLLVLDCWDHCI	TRIM32	626	Q13049
LSLHCGPWDDEIQEL	SMYD4	771	Q8IYR2
PHSCADLWDRVQCLQ	SSPOP	4686	A2VEC9
ELQCCIDWTHVTDPL	SMG5	136	Q9UPR3
PADCLLAQDLCWELL	PLEKHG4	176	Q58EX7
AEGLQELALAPCHEW	FBXL15	86	Q9H469
ELALAPCHEWLSDED	FBXL15	91	Q9H469
FDDHNLPCDVIWLDI	GANAB	416	Q14697
LHCPSDALDLWEEQL	PSD4	986	Q8NDX1
VSCCAPWFQDILHLE	SPG11	356	Q96JI7
ELGALWVCIILNPHC	ZSWIM5	416	Q9P217
IQIDLHDNPWDCTCD	SLITRK5	556	O94991
RLRELCCQWLQPEAH	ZNF446	46	Q9NWS9
CLVCLLRSWEEHNTP	TRIML1	36	Q8N9V2
ALAHLRALCCQWLQP	ZSCAN22	66	P10073
EHWLLDCAQECKHLP	TOPBP1	971	Q92547
CLHAWGLNEVLDEVC	WDR7	806	Q9Y4E6